Literature DB >> 24825793

Is "liquid biopsy" useful for assessing HER2 status in gastric cancer?

Hideaki Shimada1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24825793     DOI: 10.1007/s00535-014-0967-6

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  14 in total

1.  Evaluation of HER2-based biology in 1,006 cases of gastric cancer in a Japanese population.

Authors:  Masaki Aizawa; Akiko K Nagatsuma; Koji Kitada; Takeshi Kuwata; Satoshi Fujii; Taira Kinoshita; Atsushi Ochiai
Journal:  Gastric Cancer       Date:  2013-02-22       Impact factor: 7.370

Review 2.  Molecular targeted agents for gastric and gastroesophageal junction cancer.

Authors:  Takashi Oshima; Munetaka Masuda
Journal:  Surg Today       Date:  2011-11-30       Impact factor: 2.549

3.  Serum HER2 testing in patients with HER2-positive breast cancer: the death knell tolls.

Authors:  Brian Leyland-Jones; Brian R Smith
Journal:  Lancet Oncol       Date:  2011-03       Impact factor: 41.316

4.  Serum level of HER-2/neu in patients with gastric cancer: correlation with HER-2/neu overexpression in gastric carcinoma tissue.

Authors:  K Kono; H Naganuma; T Sekikawa; H Amemiya; A Takahashi; H Iizuka; Y Matsumoto
Journal:  Tumour Biol       Date:  2000 May-Jun

5.  Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay.

Authors:  Takuo Takehana; Kazuyoshi Kunitomo; Koji Kono; Fumiaki Kitahara; Hidehiko Iizuka; Yoshiro Matsumoto; Masayuki A Fujino; Akishi Ooi
Journal:  Int J Cancer       Date:  2002-04-20       Impact factor: 7.396

6.  Status of tissue expression and serum levels of HER2 in gastric cancer patients in Japan.

Authors:  Toru Narita; Akiyoshi Seshimo; Mamoru Suzuki; Jun Murata; Shingo Kameoka
Journal:  Hepatogastroenterology       Date:  2013 Jul-Aug

7.  A sensitive and high-throughput assay to detect low-abundance proteins in serum.

Authors:  Hongtao Zhang; Xin Cheng; Mark Richter; Mark I Greene
Journal:  Nat Med       Date:  2006-03-12       Impact factor: 53.440

Review 8.  Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association.

Authors:  Hideaki Shimada; Tamaki Noie; Manabu Ohashi; Koji Oba; Yutaka Takahashi
Journal:  Gastric Cancer       Date:  2013-04-10       Impact factor: 7.370

9.  Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?

Authors:  Natalie Turner; Marta Pestrin; Francesca Galardi; Francesca De Luca; Luca Malorni; Angelo Di Leo
Journal:  Cancers (Basel)       Date:  2014-03-25       Impact factor: 6.639

10.  Serum HER 2 extracellular domain level is correlated with tissue HER 2 status in metastatic gastric or gastro-oesophageal junction adenocarcinoma.

Authors:  Shu-Qin Dai; Xin An; Fang Wang; Qiong Shao; Yong-Chang Chen; Ya-Nan Kong; Cui Chen; Cong Li; Hui-Yan Luo; Ying Liang; Feng-Hua Wang; Rui-Hua Xu; Yu-Hong Li
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

View more
  3 in total

Review 1.  Emerging Role of MicroRNAs as Liquid Biopsy Biomarkers in Gastrointestinal Cancers.

Authors:  Kunitoshi Shigeyasu; Shusuke Toden; Timothy J Zumwalt; Yoshinaga Okugawa; Ajay Goel
Journal:  Clin Cancer Res       Date:  2017-01-31       Impact factor: 12.531

Review 2.  Next-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity.

Authors:  Daniel V T Catenacci
Journal:  Mol Oncol       Date:  2014-10-18       Impact factor: 6.603

3.  Serum HER2 as a predictive biomarker for tissue HER2 status and prognosis in patients with gastric cancer.

Authors:  Hong-Zhi Shi; Yu-Ning Wang; Xiao-Hui Huang; Ke-Cheng Zhang; Hong-Qing Xi; Jian-Xin Cui; Guo-Xiao Liu; Wen-Tao Liang; Bo Wei; Lin Chen
Journal:  World J Gastroenterol       Date:  2017-03-14       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.